Physician profile
Anthony Magalski
NPI 1912955303
$2,697.97
in general payments reported to CMS, 2019-2025
9 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Adult Congenital Heart Disease provider received nationally (typical 2025 total: $272).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2021: $666 · 2022: $406 · 2023: $319 · 2024: $449 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,367.70 | 2019-2024 | Evoque |
| Boston Scientific Corporation | $374.31 | 2023-2025 | Watchman Flx, Watchman Access System |
| Biosense Webster, INC. | $244.01 | 2025 | Nuvision Ice Catheter, Soundstar |
| Abbott Laboratories | $160.88 | 2023 | Cardiomems |
| Philips North America LLC | $149.88 | 2024 | (Ao0) Igt Devices Intracardiac |
| Portola Pharmaceuticals, LLC | $131.67 | 2019 | |
| Lantheus Medical Imaging, INC. | $112.34 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.82 | 2019 | |
| Abiomed | $47.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Magalski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.